Background No study has been conducted to specifically demonstrate the relationship between gestational diabetes mellitus (GDM) status, inflammatory factors, and postnatal umbilical coiling index (pUCI). Understanding this relationship could help select the best interventions to save the fetus. To evaluate the effects of maternal venous and umbilical cord blood levels of high sensitivity C-reactive protein (hs-CRP) and tumor necrosis factor-alpha (TNF-alpha) on pUCI in GDM and non-GDM groups. Methods This prospective observational study included 40 participants in each of the GDM and non-GDM groups, matched for maternal age, ethnicity, and parity. The GDM diagnosis was confirmed by 24 to 28 weeks of gestation (WOG) and a 2-step strategy. The covariates of interest were maternal hs-CRP and TNF-α, measured at 37 to 40 WOG, and their UC analogous was measured during delivery. The gross morphologies were assessed immediately after delivery. The UC coiling was quantitatively assessed by the pUCI. To compare the GDM and non-GDM groups, the t test and the Mann-Whitney test were used for normal and non-normal variables, respectively. Results There was not a significant difference in hs-CRP and TNF-a levels in maternal venous blood or UC blood between the GDM and non-GDM groups. The mean (SD) of pUCI in the GDM and non-GDM groups were 0.28 (0.15) and 0.24 (0.21) ( P = 0.441), respectively. In the GDM group, none of the 4 covariates of interest had significant effects on the UCI. Among the non-GDM participants, merely the UC hs-CRP had a direct association with the pUCI, with a Pearson correlation of 0.54 ( P = 0.001). Impacts of hs-CRP and TNF-α on the pUCI were assessed using Poisson regression models and no significant findings were detected (95% CI, 0.999-1.001, for all parameters). Conclusion In the GDM group, no apparent association was observed between inflammatory factors and pUCI, although a direct association was detected between UC hs-CRP and pUCI in the non-GDM.
BackgroundHence, no study has been conducted to demonstrate specifically the relationship between gestational diabetes mellitus (GDM) status, inflammatory factors, and postnatal umbilical coiling index (pUCI), as understanding this relation could help to select the best appropriate interventions to save the fetus.MethodTo assess the impact of high sensitivity C-reactive protein (hs-CRP) and Tumor necrosis factor-Alpha (TNF-α) (in maternal venous and umbilical cord (UC) blood) on pUCI, comparing GDM and non-GDM groups.This prospective observational study contained 40 parturients in each of GDM and non-GDM groups, matched for maternal age, ethnicity, and parity. GDM diagnosis was confirmed by 24–28 weeks of gestation (WOG) and two-step strategy. The covariates of interest were maternal hs-CRP and TNF-α, measured at 37-41th WOG, and their UC analogous, measured during delivery. The gross morphologies were assessed immediately after delivery. The UC coiling was quantitatively assessed by the postnatal umbilical coiling index (pUCI)..ResultsNo significant difference of hs-CRP and TNF-α, in maternal venous blood or UC blood, was found between GDM/non-GDM groups. The mean (SD) of pUCI in GDM and non-GDM groups were 0.28 (0.15) and 0.24 (0.21) (p-value = 0.441), respectively. In GDM group, none of the four covariates of interest had significant effects on pUCI. Among the non-GDM patients, merely the UC hs-CRP had a direct association with pUCI, a Pearson correlation of r = 0.54 (p-value < .01).ConclusionsIn GDM group, no apparent relationship was observed between inflammatory factors and pUCI, although a direct association was detected between UC hs-CRP and pUCI in the non-GDM.Tweetable abstractThe umbilical cord high sensitivity C-reactive protein is directly correlated with postnatal umbilical coiling.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.